Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
about
Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.Metabolic syndrome in rheumatoid arthritis: case control studyRheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.Locomotion and muscle mass measures in a murine model of collagen-induced arthritis.Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medicationResting energy expenditure is not associated with disease activity in women with rheumatoid arthritis: cross-sectional study.Effect of body composition on bone mineral density in Moroccan patients with juvenile idiopathic arthritis.Determinants of changes in linear growth and body composition in incident pediatric Crohn's diseaseSerum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children.Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 monthsEvaluation of the anti-arthritic activity of the hydroethanolic leaf extract of Alchornea cordifolia in rats.Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study.Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeysA close association of body cell mass loss with disease activity and disability in Chinese patients with rheumatoid arthritis.Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis.Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritisChanges in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.Redefining overweight and obesity in rheumatoid arthritis patients.Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control studyMetabolic syndrome in rheumatoid arthritisTriptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway.Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study.Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.Rheumatoid cachexia: a clinical perspective.Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease.A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology.Sarcopenia in women with rheumatoid arthritis.Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study.Acute resistance exercise reduces increased gene expression in muscle atrophy of ovariectomised arthritic rats.Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study.Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors.Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations.
P2860
Q24812664-F021051D-FE2A-43A2-B646-D06DE3A5B703Q31116097-6067A71F-7B29-4AAE-8612-06D8A3FB0988Q33307666-317C179F-C649-44B3-95C5-C90DBC329475Q33459510-A4CB290B-F86D-456E-B4A4-4FB5DF084B8BQ33792588-7040E323-BDCE-4BA1-A345-83295C0E3E7AQ33912921-6A7F3A9A-0856-4CB7-AA51-15ED635B2A8EQ33991868-3C429409-B743-41B3-88D6-EB14D85C3487Q34023127-5370D9D4-3C8F-45E9-BC6D-AF100C8EF345Q34073420-EB46CF84-4544-486B-9468-8D8A9EBF2C56Q34346418-01D7ED97-8CDA-418F-9A83-580B57A9DFE9Q34368487-FA399BB0-F38C-4859-B1F6-AD6AFFA72191Q34461706-4CD6D940-5A96-46B0-AD97-1344D0ABF8D7Q34802678-E75F3FD2-EC33-4284-9186-29F8A110D923Q35141960-06BF3E12-27F5-4FBF-BD03-7A4329287DF1Q35556074-0EEA8BA1-49FD-44C8-BF95-22B93AAA12DDQ35596467-F8CC2637-0AE6-4D1C-82F4-9B60CBA25679Q35636564-7EC6B5FD-E20E-4FD4-A5A6-DE4B010D0E5DQ35637875-98216442-9118-4832-B1D0-832EF81581A0Q35868276-49C02855-F92F-48A5-8AEA-4DE46B33C9FAQ36013923-481A94EB-E7CB-41FC-B332-980E9AAA9C3CQ36052572-A676F342-6161-4FEB-A17A-ACA94CC5D3A6Q36392385-5EBA3E8B-0567-40D6-A66F-CCFC1A24A2C2Q36568868-1D30C00E-06C4-4E19-AC8C-AAEEC3258D2BQ36723165-C0EBBC52-2938-4E5C-AF54-19AB3DC7E089Q36790369-5C023F7B-15FA-4744-8A2E-745797069712Q37058791-7932F957-9000-4288-BCB9-B2721940DADCQ37087686-1EC07233-7A1F-4518-9668-F16D5DEC63AEQ37129611-B2218DBA-F22A-45FE-9343-F608D3A78E49Q37151582-0FA7FE2D-EF8D-47F0-A5E8-AB6C8FE855AFQ37250460-220A716B-257C-4AD5-B508-D1BE134768ABQ37301169-C53E4A6D-0463-4640-A6C2-0E98E604DD77Q37305184-0D149D40-9A69-484F-954C-141E37F08367Q37350896-0C62F888-A575-45AD-B85A-F26A6B752C5CQ37389102-3A629021-3EFB-414D-BFB0-46AD6A045ED7Q37668490-DABBB13A-B5B5-4BB0-BA88-2203DEDFE8E4Q37691220-A42C30D2-3EC0-49A8-A085-DEFBA3F23BB5Q38206735-6716D4C3-1821-4FEB-96AC-24AA547536F4Q38323310-C349978D-9BC8-4F7B-A9D9-28D7360A49E6Q38405205-32F3DD95-1AE9-4800-B118-E9777253C5C9Q38763702-BFDB9BFA-3E04-44AA-A7A8-7438EF8F6856
P2860
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
@ast
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
@en
type
label
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
@ast
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
@en
prefLabel
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
@ast
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.
@en
P356
P1433
P1476
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEH321
P577
2004-08-03T00:00:00Z